Jonathan MacQuitty
Investing Profile
Sweet spot: $15M
Range: $3M–$20M
Sector and stage focus
- Series B: BioTech, Pharmaceuticals, Health & Hospital Services, Health IT
- Series A: BioTech, Health IT, Pharmaceuticals, Health & Hospital Services
- general: San Francisco Bay Area
Recent investments by Jonathan MacQuitty
Jonathan MacQuitty has 7 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Odyssey Therapeutics | Series D | Sep 2025 | $210M |
| Neuralink | Series E | May 2025 | $650M |
| Antares Therapeutics | Series A | May 2025 | $180M |
| Ultima Genomics | Series Unknown | May 2022 | $600M |
| Aledade | Series F | Jun 2023 | $260M |
| Ancora Biotech | Series A | Jun 2022 | $60M |
| Frontera Health | Seed | Feb 2025 | $32M |
Frequent co-investors
Jonathan MacQuitty has co-invested with: Ravi Mhatre, David Krane, Krishna Yeshwant, Peter Thiel, Blake Byers, Ken Howery.
Is Jonathan MacQuitty a fit for your round?
Upload your pitch deck and see whether Jonathan MacQuitty appears in your top 20 matches.
Find investors for your deck